Harvard Bioscience (HBIO) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	5.35M
Accounts receivable, net of allowance for doubtful accounts of $281 and $273, respectively	15.12M
Inventories	21.23M
Deferred income tax assets - current	0
Other receivables and other assets	4.46M
Total current assets	46.15M
Property, plant and equipment, net	5.27M
Deferred income tax assets - non-current	931K
Amortizable intangible assets, net	18.86M
Goodwill	39.62M
Other indefinite lived intangible assets	1.23M
Other assets	112K
Total assets	112.18M
Accounts payable	6.14M
Deferred revenue	729K
Accrued income taxes payable	218K
Accrued expenses	4.5M
Other liabilities - current	478K
Total current liabilities	14.44M
Long-term debt, less current installments	12.67M
Deferred income tax liabilities - non-current	6.53M
Other liabilities - non-current	2.64M
Total liabilities	36.29M
Commitments and contingencies
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized	0
Common stock, par value $0.01 per share, 80,000,000 shares authorized; 36,217,732 and 36,057,974 shares issued and 28,472,225 and 28,312,467 shares outstanding, respectively	417K
Additional paid-in-capital	214.13M
Accumulated deficit	-114.71M
Accumulated other comprehensive income	-13.28M
Treasury stock at cost, 7,745,507 common shares	-10.67M
Total stockholders' equity	75.89M
Total Liabilities And Stockholders Equity	112.18M

Entities mentioned with HBIO

View All Entities